Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.
- Conditions
- HDFN
- Registration Number
- NCT02969174
- Lead Sponsor
- Shanghai Tongji Hospital, Tongji University School of Medicine
- Brief Summary
To establish a genotyping and extraction technology of non invasive prenatal diagnosis for fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women.
To achieve prenatal accurate identification of fetal blood group genotypes，and provide credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease of newborn (HDN).
- Detailed Description
Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.
Recruitment & Eligibility
- Status
- APPROVED_FOR_MARKETING
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
blood samples of pregnant couples,gender/nation/region is unlimited.
Exclusion Criteria
adipose or hemolytic samples,overdue samples,unidentified samples
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method